CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma

BACKGROUND: Comparative genetic and biological studies on malignant tumor counterparts in human beings and laboratory mice may be powerful gene discovery tools for blood cancers, including neoplasms of mature B-lymphocytes and plasma cells such as Burkitt lymphoma (BL) and multiple myeloma (MM). MET...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Exp Hematol Oncol
Autori principali: Han, Seong-Su, Tompkins, Van S, Son, Dong-Ju, Han, Sangwoo, Yun, Hwakyung, Kamberos, Natalie L, Dehoedt, Casey L, Gu, Chunyan, Holman, Carol, Tricot, Guido, Zhan, Fenghuang, Janz, Siegfried
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4383050/
https://ncbi.nlm.nih.gov/pubmed/25838973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-015-0005-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi